Abstract:The level of surveillance and preparedness against epidemics varies across countries, resulting in different responses to outbreaks. When conducting an in-depth analysis of microinfection dynamics, one must account for the substantial heterogeneity across countries. However, many commonly used statistical model specifications lack the flexibility needed for sound and accurate analysis and prediction in such contexts. Nonlinear mixed effects models (NLMMs) constitute a specific statistical tool that can overcome these significant challenges. While compartmental models are well-established in infectious disease modeling and have seen significant advancements, Nonlinear Mixed Models (NLMMs) offer a flexible approach for handling heterogeneous and unbalanced repeated measures data, often with less computational effort than some individual-level compartmental modeling techniques. This study provides an overview of their current use and offers a solid foundation for developing guidelines that may help improve their implementation in real-world situations. Relevant scientific databases in the Research4life Access initiative programs were used to search for papers dealing with key aspects of NLMMs in infectious disease modeling (IDM). From an initial list of 3641 papers, 124 were finally included and used for this systematic and critical review spanning the last two decades, following the PRISMA guidelines. NLMMs have evolved rapidly in the last decade, especially in IDM, with most publications dating from 2017 to 2021 (83.33%). The routine use of normality assumption appeared inappropriate for IDM, leading to a wealth of literature on NLMMs with non-normal errors and random effects under various estimation methods. We noticed that NLMMs have attracted much attention for the latest known epidemics worldwide (COVID-19, Ebola, Dengue and Lassa) with the robustness and reliability of relaxed propositions of the normality assumption. A case study of the application of COVID-19 data helped to highlight NLMMs' performance in modeling infectious diseases. Out of this study, estimation methods, assumptions, and random terms specification in NLMMs are key aspects requiring particular attention for their application in IDM.

GENERALIZED LINEAR MIXED MODELS AND ITS APPLICATION

Linear mixed effects models for non‐Gaussian continuous repeated measurement data

Mixed Model Applications to the Analysis of Repeated Measures Data in Clinical Trials

Mixed Linear Model Approaches for Analyzing Genetic Models of Complex Quantitative Traits

Covariate-adjusted response-adaptive designs for generalized linear models

Asymptotic Properties of Estimation in Generalized Partial Linear Mixed Models

Clustering populations by mixed linear models

Joint analysis of nonlinear heterogeneous longitudinal data and binary outcome: an application to AIDS clinical studies

Using a centered general linear model for detection of interactions among biomarkers

Generalized Linear Latent Variable Modeling for Multi-Group Studies

Joint model-based clustering of nonlinear longitudinal trajectories and associated time-to-event data analysis, linked by latent class membership: with application to AIDS clinical studies

An Introduction of GAM in Identifying Non-linear Correlations and its Application in Statistical Modeling

Mixture random effect model based meta-analysis for medical data mining

Linear Mixed-Effects Models for Non-Gaussian Repeated Measurement Data

Linear mixed models with endogenous covariates: modeling sequential treatment effects with application to a mobile health study

Inference for High-Dimensional Linear Mixed-Effects Models: A Quasi-Likelihood Approach

Nonlinear mixed models and related approaches in infectious disease modeling: A systematic and critical review

Linear mixed models with marginally symmetric nonparametric random effects

Model Specification in Mixed-Effects Models: A Focus on Random Effects

Causal Inference using Multivariate Generalized Linear Mixed-Effects Models with Longitudinal Data

Variable Selection for Mixed Panel Count Data under the Proportional Mean Model.